Dr. Cataland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
456 W 10th Ave
Columbus, OH 43210Phone+1 614-292-3800Fax+1 614-292-1550- Is this information wrong?
Summary
- Dr. Samuel Cataland is an endocrinologist in Columbus, OH and is affiliated with multiple hospitals in the area, including James Cancer Hospital and Solove Research Institute and Ohio State University Wexner Medical Center. He received his medical degree from The Ohio State University College of Medicine and has been in practice 52 years. He specializes in diabetes and lipid metabolism.
Education & Training
Ohio State University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1968 - 1970- Ohio State University HospitalResidency, Internal Medicine, 1968 - 1970
Mount Carmel Health SystemResidency, Internal Medicine, 1967 - 1968
University of Kentucky College of MedicineResidency, Internal Medicine, 1966 - 1967- Mount Carmel Health SystemInternship, Transitional Year, 1965 - 1966
- Ohio State University College of MedicineClass of 1965
Certifications & Licensure
OH State Medical License 1965 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Caplacizumab reduces the frequency of major thromboembolic events, exacerbations, and death in patients with acquired thrombotic thrombocytopenic purpura.Peyvandi, F.,Scully, M.,Kremer Hovinga, J. A.,Knöbl, P.,Cataland, S.,De Beuf, K.,Callewaert, F.,De Winter, H.,Zeldin, R. K.> ;J. Thromb. Haemost.. 2017 Apr 27
- 73 citationsThe Semmes–Weinstein Monofilament as a Potential Predictor of Foot Ulceration in Patients With Noninsulin-Dependent DiabetesPablo Olmos, Samuel Cataland, Thomas M. O'Dorisio, Cecilia A. Casey, William L. Smead, Sheldon R. Simon> ;The American Journal of the Medical Sciences. 1995 Feb 1
- 21 citationsMetabolic effects of long-acting somatostatin analogue (sandostatin) in type I diabetic patients on conventional therapy.Kwame Osei, Thomas M. O'Dorisio, William B. Malarkey, Elson L. Craig, Samuel Cataland> ;Diabetes. 1989 Jun 1
- Join now to see all
Hospital Affiliations
The OSUCCC - JamesColumbus, Ohio
Ohio State University Wexner Medical CenterColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
